CSTL
USDCastle Biosciences Inc. Common Stock
$33.815+0.705 (2.129%)
Real-time Price
Healthcare
Diagnostics & Research
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$33.110
High
$34.340
Low
$32.510
Volume
0.67M
Company Fundamentals
Market Cap
987.0M
Industry
Diagnostics & Research
Country
United States
Trading Stats
Avg Volume
0.44M
Exchange
NGM
Currency
USD
52-Week Range
Low $14.59Current $33.815High $34.64
Related News
Analyst Upgrades
BTIG Maintains Buy on Castle Biosciences, Raises Price Target to $38
BTIG analyst Mark Massaro maintains Castle Biosciences with a Buy and raises the price target from $32 to $38.
View more
Analyst Upgrades
Baird Maintains Outperform on Castle Biosciences, Raises Price Target to $41
Baird analyst Catherine Ramsey maintains Castle Biosciences with a Outperform and raises the price target from $39 to $41.
View more
GlobeNewswire
Castle Biosciences Reports Third Quarter 2025 Results
Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.